article thumbnail

Epilepsy and MMJ: Exploring the Promising Treatment Benefits

MMJ Recs

Epilepsy is a complex neurological disorder that affects millions of people worldwide, causing recurrent seizures that can significantly impact the quality of life. Medical Marijuana for Epilepsy Treatment Medical marijuana, often referred to as MMJ, is a term used to describe the use of cannabis and its derivatives for therapeutic purposes.

Epilepsy 105
article thumbnail

10 Tips for Buying CBD Oil

Project CBD

In June 2018, the Food and Drug Administration ( FDA ) gave its blessing to “Epidiolex,” a purfied CBD pharmaceutical, for treating severe pediatric epilepsy.

Oil 237
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Charlotte’s Web CBD Banned by British Regulators

Veriheal

Three different types of cannabidiol (CBD) oils produced by Charlotte’s Web have been banned by British regulators. The British Food Standards Agency (FSA) has also disqualified approximately 100 CBD products for undisclosed reasons. Despite the law’s passing, CBD is still widely unregulated in the United Kingdom.

CBD 94
article thumbnail

What is CBD? Everything you need to know

The Cannigma

Close behind it — in both regards — is CBD, which despite having been studied for decades, has only become the center of a billion dollar industry in recent years. Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. CBD vs THC. CBD vs CBDA.

CBD 122
article thumbnail

Trema micrantha: Scientists Discover CBD Traits in South American Shrub

Veriheal

In the new yet-to-be-published study, researchers led by Rodrigo Moura Neto, a Molecular Biologist at the Federal University of Rio de Janeiro, discovered a CBD-like compound in Trema micrantha, a common plant in Brazil. Presently, CBD is inarguably the most acceptable compound in cannabis.

CBD 93
article thumbnail

CBD is on a Roll, but the FDA is Hitting the Brakes

MJ Business Attorneys

market for CBD continues to skyrocket and companies competing in the cannabis space become more developed, they are being held back by the slow federal regulatory response at the Food and Drug Administration. ” Curaleaf is the first multistate CBD company to receive such a notice from the FDA. CBD sales by 2023.

CBD 133
article thumbnail

GW suffers major blow as US sinks bid to patent cannabinoids for epilepsy

Cannabis Law Report

British firm GW Pharmaceuticals is licking its wounds after US judges tossed out its attempt to patent multiple cannabinoids for epilepsy treatment following an eight-year battle. The patent, which has been embroiled in dispute since 2010, is for “the use of one or more cannabinoids in the treatment of epilepsy”.